Connection
Co-Authors
This is a "connection" page, showing publications co-authored by Janet Snell-Bergeon and Meghan Pauley.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
1.433 |
|
|
|
-
Pauley ME, Coughlan C, Dong F, Bucca B, Tanner B, Chartier-Logan C, Shapiro ALB, Snell-Bergeon JK. Type 1 diabetes is associated with higher plasma levels of biomarkers of neurodegeneration and neuroinflammation. Front Immunol. 2026; 17:1860993.
Score: 0.995
-
Stein A, Pauley M, Snell-Bergeon J. Weekly Glucagon-Like Peptide-1 Receptor Agonists in Type 1 Diabetes: What We Know So Far and Future Trials. Endocrinol Metab Clin North Am. 2026 Sep; 55(3):437-453.
Score: 0.246
-
Pauley ME, Tommerdahl KL, Snell-Bergeon JK, Forlenza GP. Continuous Glucose Monitor, Insulin Pump, and Automated Insulin Delivery Therapies for Type 1 Diabetes: An Update on Potential for Cardiovascular Benefits. Curr Cardiol Rep. 2022 12; 24(12):2043-2056.
Score: 0.192